- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.01. | Siemens Healthineers unveils $12M R&D facility in Ireland | ||
| 30.01. | Stryker's 2025 Q4 earnings exceed Wall Street predictions | ||
| 29.01. | Senseonics wins CE mark for Eversense 365 year-long CGM | ||
| 29.01. | Siemens Healthineers wins FDA nod for PET/MR imaging scanner | ||
| 29.01. | The top 10 cardio device stories of 2025 | ||
| 29.01. | Glucotrack picks up new patents for continuous blood glucose monitor | ||
| 29.01. | Cortigent reports positive 6-year findings for brain implant for providing artificial vision | ||
| 29.01. | Imperative Care launches new Zoom 4S catheter | ||
| 29.01. | FDA clears eMurmur's next-gen AI heart murmur detection software | ||
| 28.01. | Organon completes divestiture of Jada intrauterine vacuum device to Laborie | ||
| 28.01. | Olympus launches single-use fine needle biopsy device in US | ||
| 28.01. | Ultrasonic robotic surgery tech developer Nami Surgical names new CEO, brings in $2.6M | ||
| 28.01. | Biotronik completes first human implants of LivIQ leadless pacemaker | ||
| 28.01. | Johnson & Johnson MedTech hits $100M medtech product donation milestone | ||
| 27.01. | Abbott: Study shows neuromod systems greatly reduce pain-related healthcare visits | ||
| 27.01. | Boston Scientific completes Nalu Medical acquisition | ||
| 27.01. | 4DMedical raises $100M to support software-based lung imaging tech | ||
| 27.01. | BD sets date for spin-off of Biosciences & Diagnostics Solutions business to Waters | ||
| 27.01. | Outset Medical wins FDA nod for next-gen Tablo hemodialysis system | ||
| 27.01. | Robocath launches first-in-human study of next-gen robot for coronary artery disease | ||
| 27.01. | Oath Surgical, Nvidia collaborate on AI-native surgical centers | ||
| 27.01. | Masimo combats Apple attempt to avoid $634M patent spat payment | ||
| 26.01. | Penumbra launches next-gen Lightning Flash 3.0 thrombectomy system | ||
| 26.01. | Shifamed's Myra Vision treats first glaucoma patient in Calibreye clinical trial | ||
| 26.01. | Olympus recommends removal of discontinued insufflation units |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.